The role of hypoxia inducible factor-1 in hepatocellular carcinoma

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Luo, Dongjun ^a   Wang, Zhongxia ^b   Wu, Junyi ^c   Jiang, Chunping ^a,b   Wu, Junhua ^c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^c NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1 INHIBITOR; PROTEIN INHIBITOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTISENSE THERAPY; APOPTOSIS; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GENE THERAPY; CANCER GROWTH; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RESISTANCE; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL TRIAL (TOPIC); ERYTHROPOIESIS; GENE OVEREXPRESSION; GLUCOSE METABOLISM; HUMAN; HYPOXEMIA; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; METABOLISM; METASTASIS; NONHUMAN; ONCOGENE; PROTEIN DEGRADATION; PROTEIN STABILITY; REGULATORY MECHANISM; REVIEW; RNA INTERFERENCE; TRANSCRIPTION INITIATION; TUMOR INVASION; TUMOR MICROENVIRONMENT; BIOSYNTHESIS; CARCINOGENESIS; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; SIGNAL TRANSDUCTION;

CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; LIVER NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION;

EID: 84904788576     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/409272     Document Type: Review

References (108)

1. Lin S., Hoffmann K., Schemmer P., Treatment of hepatocellular carcinoma: a systematic review. Liver Cancer 2012 1 3-4 144 158
2. Moeini A., Cornellà H., Villanueva A., Emerging signaling pathways in hepatocellular carcinoma. Liver Cancer 2012 1 2 83 93
3. Myung S. J., Yoon J., Hypoxia in hepatocellular carcinoma. The Korean journal of hepatology 2007 13 1 9 19 2-s2.0-34548793225
4. Semenza G. L., Wang G. L., A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Molecular and Cellular Biology 1992 12 12 5447 5454 2-s2.0-0026468180
5. Jiang B., Rue E., Wang G. L., Roe R., Semenza G. L., Dimerization, DNA binding, and transactivation properties of hypoxia- inducible factor 1. The Journal of Biological Chemistry 1996 271 30 17771 17778 10.1074/jbc.271.30.17771 2-s2.0-0029944965 (Pubitemid 26250751)
6. Li H., Ko H. P., Whitlock J. P. Jr., Induction of phosphoglycerate kinase 1 gene expression by hypoxia. Roles of Arnt and HIF1alpha. Journal of Biological Chemistry 1996 271 35 21262 21267 10.1074/jbc.271.35.21262 2-s2.0-0029788974 (Pubitemid 26292983)
7. Kaelin W. G. Jr., Proline hydroxylation and gene expression. Annual Review of Biochemistry 2005 74 115 128 10.1146/annurev.biochem.74.082803.133142 2-s2.0-22244440847 (Pubitemid 40995503)
8. Berra E., Benizri E., Ginouvès A., Volmat V., Roux D., Pouysségur J., HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1 α in normoxia. The EMBO Journal 2003 22 16 4082 4090 10.1093/emboj/cdg392 2-s2.0-0041465022 (Pubitemid 37021737)
9. Jeong J., Bae M., Ahn M., Kim S., Sohn T., Yoo M., Song E. J., Lee K., Kim K., Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation. Cell 2002 111 5 709 720 10.1016/S0092-8674(02)01085-1 2-s2.0-18744375998 (Pubitemid 35441252)
10. Bae S., Jeong J., Park J. A., Kim S., Bae M., Choi S., Kim K., Sumoylation increases HIF-1 α stability and its transcriptional activity. Biochemical and Biophysical Research Communications 2004 324 1 394 400 10.1016/j.bbrc.2004.09.068 2-s2.0-4744353220 (Pubitemid 39311508)
11. Carbia-Nagashima A., Gerez J., Perez-Castro C., Paez-Pereda M., Silberstein S., Stalla G. K., Holsboer F., Arzt E., RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia. Cell 2007 131 2 309 323 10.1016/j.cell.2007.07.044 2-s2.0-35348904953 (Pubitemid 47592916)
12. Cheng J., Kang X., Zhang S., Yeh E. T. H., SUMO-specific protease 1 is essential for stabilization of HIF1 α during hypoxia. Cell 2007 131 3 584 595 10.1016/j.cell.2007.08.045 2-s2.0-35548935098 (Pubitemid 350007694)
13. 2-independent and HSP90 inhibitor-induced degradation of HIF-1 α Molecular Cell 2007 25 2 207 217 10.1016/j.molcel.2007.01.001 2-s2.0-33846254999 (Pubitemid 46109612)
14. Isaacs J. S., Jung Y., Mimnaugh E. G., Martinez A., Cuttitta F., Neckers L. M., Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway. Journal of Biological Chemistry 2002 277 33 29936 29944 10.1074/jbc.M204733200 2-s2.0-0037119415
15. Depping R., Steinhoff A., Schindler S. G., Friedrich B., Fagerlund R., Metzen E., Hartmann E., Köhler M., Nuclear translocation of hypoxia-inducible factors (HIFs): involvement of the classical importin α / β pathway. Biochimica et Biophysica Acta: Molecular Cell Research 2008 1783 3 394 404 10.1016/j.bbamcr.2007.12.006 2-s2.0-39149098464
16. Hewitson K. S., McNeill L. A., Riordan M. V., Tian Y., Bullock A. N., Welford R. W., Elkins J. M., Oldham N. J., Bhattacharya S., Gleadle J. M., Ratcliffe P. J., Pugh C. W., Schofield C. J., Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. The Journal of Biological Chemistry 2002 277 29 26351 26355 10.1074/jbc.C200273200 2-s2.0-18544386401 (Pubitemid 34967127)
17. Koivunen P., Hirsilä M., Günzler V., Kivirikko K. I., Myllyharju J., Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases. Journal of Biological Chemistry 2004 279 11 9899 9904 10.1074/jbc.M312254200 2-s2.0-1642315195 (Pubitemid 38372589)
18. Tian Y. M., Yeoh K. K., Lee M. K., Eriksson T., Kessler B. M., Kramer H. B., Edelmann M. J., Willam C., Pugh C. W., Schofield C. J., Ratcliffe P. J., Differential sensitivity of hypoxia inducible factor hydroxylation sites to hypoxia and hydroxylase inhibitors. The Journal of Biological Chemistry 2011 286 15 13041 13051 10.1074/jbc.M110.211110 2-s2.0-79953891392
19. Hong S. S., Lee H., Kim K. W., HIF-1alpha: a valid therapeutic target for tumor therapy. Cancer Research and Treatment 2004 36 6 343 353 10.4143/crt.2004.36.6.343
20. Burroughs S. K., Kaluz S., Wang D., Wang K., Van Meir E. G., Wang B., Hypoxia inducible factor pathway inhibitors as anticancer therapeutics. Future Medicinal Chemistry 2013 5 5 553 572 10.4155/fmc.13.17 2-s2.0-84876133472
21. Hicklin D. J., Ellis L. M., Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. Journal of Clinical Oncology 2005 23 5 1011 1027 10.1200/JCO.2005.06.081 2-s2.0-14644440555 (Pubitemid 46202320)
22. Melillo G., Musso T., Sica A., Taylor L. S., Cox G. W., Varesio L., A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. Journal of Experimental Medicine 1995 182 6 1683 1693 10.1084/jem.182.6.1683 2-s2.0-0028786601
23. Hu J., Discher D. J., Bishopric N. H., Webster K. A., Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor-1 binding site on the antisense strand. Biochemical and Biophysical Research Communications 1998 245 3 894 899 10.1006/bbrc.1998.8543 2-s2.0-0032576971 (Pubitemid 28414014)
24. Ceradini D. J., Kulkarni A. R., Callaghan M. J., Tepper O. M., Bastidas N., Kleinman M. E., Capla J. M., Galiano R. D., Levine J. P., Gurtner G. C., Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nature Medicine 2004 10 8 858 864 10.1038/nm1075 2-s2.0-4043184065 (Pubitemid 39070860)
25. Simon M. P., Tournaire R., Pouyssegur J., The angiopoietin-2 gene of endothelial cells is up-regulated in hypoxia by a HIF binding site located in its first intron and by the central factors GATA-2 and Ets-1. Journal of Cellular Physiology 2008 217 3 809 818 10.1002/jcp.21558 2-s2.0-54049146968
26. Huang Y., Hickey R. P., Yeh J. L., Liu D., Dadak A., Young L. H., Johnson R. S., Giordano F. J., Cardiac myocyte-specific HIF-1alpha deletion alters vascularization, energy availability, calcium flux, and contractility in the normoxic heart. The FASEB Journal 2004 18 10 1138 1140 10.1096/fj.04-1510fje 2-s2.0-4444379952 (Pubitemid 39561549)
27. Grosfeld A., André J., de Mouzon S. H., Berra E., Pouysségur J., Guerre-Millo M., Hypoxia-inducible factor 1 transactivates the human leptin gene promoter. The Journal of Biological Chemistry 2002 277 45 42953 42957 10.1074/jbc.M206775200 2-s2.0-0037044813 (Pubitemid 35285673)
28. Semenza G. L., HIF-1: upstream and downstream of cancer metabolism. Current Opinion in Genetics and Development 2010 20 1 51 56 10.1016/j.gde.2009. 10.009 2-s2.0-76049100577
29. Semenza G. L., Regulation of cancer cell metabolism by hypoxia-inducible factor 1. Seminars in Cancer Biology 2009 19 1 12 16 10.1016/j.semcancer.2008. 11.009 2-s2.0-60549083256
30. Denko N. C., Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nature Reviews Cancer 2008 8 9 705 713 10.1038/nrc2468 2-s2.0-50149097983
31. Chen C., Pore N., Behrooz A., Ismail-Beigi F., Maity A., Regulation of glut1 mRNA by hypoxia-inducible factor-1: interaction between H-ras and hypoxia. The Journal of Biological Chemistry 2001 276 12 9519 9525 10.1074/jbc. M010144200 2-s2.0-0035937715
32. Mathupala S. P., Rempel A., Pedersen P. L., Glucose catabolism in cancer cells: identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions. Journal of Biological Chemistry 2001 276 46 43407 43412 10.1074/jbc.M108181200 2-s2.0-0035900767
33. Firth J. D., Ebert B. L., Ratcliffe P. J., Hypoxic regulation of lactate dehydrogenase A. Interaction between hypoxia-inducible factor I and cAMP response elements. Journal of Biological Chemistry 1995 270 36 21021 21027 10.1074/jbc.270.36.21021 2-s2.0-0029101515
34. Ullah M. S., Davies A. J., Halestrap A. P., The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1 α -dependent mechanism. The Journal of Biological Chemistry 2006 281 14 9030 9037 10.1074/jbc.M511397200 2-s2.0-33646917296 (Pubitemid 43864615)
35. Kim J. W., Tchernyshyov I., Semenza G. L., Dang C. V., HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metabolism 2006 3 3 177 185 10.1016/j.cmet.2006.02.002 2-s2.0-33644614520
36. Zhang H., Gao P., Fukuda R., Kumar G., Krishnamachary B., Zeller K. I., Dang C., Semenza G. L., HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell 2007 11 5 407 420 10.1016/j.ccr.2007.04.001 2-s2.0-34247614521 (Pubitemid 46670080)
37. Feldser D., Agani F., Iyer N. V., Pak B., Ferreira G., Semenza G. L., Reciprocal positive regulation of hypoxia-inducible factor 1 α and insulin-like growth factor 2. Cancer Research 1999 59 16 3915 3918 2-s2.0-0033566693 (Pubitemid 29393552)
38. Chang L. H., Pan S. L., Lai C. Y., Tsai A., Teng C., Activated PAR-2 regulates pancreatic cancer progression through ILK/HIF- α -induced TGF- α expression and MEK/VEGF-a-mediated angiogenesis. The American Journal of Pathology 2013 183 2 566 575 10.1016/j.ajpath.2013.04.022 2-s2.0-84880634202
39. Koshiji M., Kageyama Y., Pete E. A., Horikawa I., Barrett J. C., Huang L. E., HIF-1alpha induces cell cycle arrest by functionally counteracting Myc. The EMBO Journal 2004 23 9 1949 1956 10.1038/sj.emboj.7600196 2-s2.0-3142631736 (Pubitemid 38902073)
40. Löfstedt T., Jögi A., Sigvardsson M., Gradin K., Poellinger L., Påhlman S., Axelson H., Induction of ID2 expression by hypoxia-inducible factor-1. A role in dedifferentiation of hypoxic neuroblastoma cells. Journal of Biological Chemistry 2004 279 38 39223 39231 10.1074/jbc.M402904200 2-s2.0-4544361863 (Pubitemid 39258183)
41. Ladelfa M. F., Toledo M. F., Laiseca J. E., Monte M., Interaction of p53 with tumor suppressive and oncogenic signaling pathways to control cellular reactive oxygen species production. Antioxidants & Redox Signaling 2011 15 6 1749 1761 10.1089/ars.2010.3652 2-s2.0-79960027346
42. Song Z. C., Zhou W., Shu R., Ni J., Hypoxia induces apoptosis and autophagic cell death in human periodontal ligament cells through HIF-1 α pathway. Cell Proliferation 2012 45 3 239 248 10.1111/j.1365-2184.2012.00810.x 2-s2.0-84859874179
43. Volm M., Koomägi R., Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer. Anticancer Research 2000 20 3 A 1527 1533 2-s2.0-0342433777 (Pubitemid 30628160)
44. Ben-Yosef Y., Lahat N., Shapiro S., Bitterman H., Miller A., Regulation of endothelial matrix metalloproteinase-2 by hypoxia/reoxygenation. Circulation Research 2002 90 7 784 791 10.1161/01.RES.0000015588.70132.DC 2-s2.0-0037134413 (Pubitemid 34633894)
45. Ryu M. H., Park H. M., Chung J., Lee C. H., Park H. R., Hypoxia-inducible factor-1 α mediates oral squamous cell carcinoma invasion via upregulation of α 5 integrin and fibronectin. Biochemical and Biophysical Research Communications 2010 393 1 11 15 10.1016/j.bbrc.2010.01.060 2-s2.0-77549085095
46. Pennacchietti S., Michieli P., Galluzzo M., Mazzone M., Giordano S., Comoglio P. M., Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 2003 3 4 347 361 10.1016/S1535-6108(03) 00085-0 2-s2.0-0037478437 (Pubitemid 38340304)
47. Niizeki H., Kobayashi M., Horiuchi I., Akakura N., Chen J., Wang J., Hamada J.-., Seth P., Katoh H., Watanabe H., Raz A., Hosokawa M., Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cells. British Journal of Cancer 2002 86 12 1914 1919 10.1038/sj.bjc.6600331 2-s2.0-18544384240
48. Krishnamachary B., Berg-Dixon S., Kelly B., Agani F., Feldser D., Ferreira G., Iyer N., LaRusch J., Pak B., Taghavi P., Semenza G. L., Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Research 2003 63 5 1138 1143 2-s2.0-0037374289 (Pubitemid 36278449)
49. Xia L., Mo P., Huang W., Zhang L., Wang Y., Zhu H., Tian D., Liu J., Chen Z., Zhang Y., Hu H., Fan D., Nie Y., Wu K., The TNF- α /ROS/HIF-1-induced upregulation of foxMI expression promotes HCC proliferation and resistance to apoptosis. Carcinogenesis 2012 33 11 2250 2259 10.1093/carcin/bgs249 2-s2.0-84868616470
50. Xu Z., Liu E., Peng C., Li Y., He Z., Zhao C., Niu J., Role of hypoxia-inducible-1alpha in hepatocellular carcinoma cells using a Tet-on inducible system to regulate its expression in vitro. Oncology Reports 2012 27 2 573 578 10.3892/or.2011.1533 2-s2.0-84862956323
51. Xu Z., Chen X., Niu J., Liu E., Li C., Peng C., The prognostic significance of Omi/HtrA2 expression, and correlation between Omi/HtrA2 and hypoxia-inducible factor-1 α in primary hepatocellular carcinoma cells. Zhonghua Wai Ke Za Zhi 2012 50 1 49 52 2-s2.0-84875590223
52. Xu Z., Chen X., Peng C., Liu E., Li Y., Li C., Niu J., Hypoxia-inducible factor- α suppressed hepatocellular carcinoma cell apoptosis through influencing on Omi/HtrA2 expression and its releasing from the mitochondrion. Oncology Research 2013 20 5-6 213 220 10.3727/096504013X13589503482815 2-s2.0-84875606817
53. Jeon Y. K., Yoo D. R., Jang Y. H., Jang S. Y., Nam M. J., Sulforaphane induces apoptosis in human hepatic cancer cells through inhibition of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase4, mediated by hypoxia inducible factor-1-dependent pathway. Biochimica et Biophysica Acta 2011 1814 10 1340 1348 10.1016/j.bbapap.2011.05.015 2-s2.0-80051665521
54. Zhang H., Bosch-Marce M., Shimoda L. A., Yee S. T., Jin H. B., Wesley J. B., Gonzalez F. J., Semenza G. L., Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. The Journal of Biological Chemistry 2008 283 16 10892 10903 10.1074/jbc.M800102200 2-s2.0-43649104579
55. Sermeus A., Michiels C., Reciprocal influence of the p53 and the hypoxic pathways. Cell Death & Disease 2011 2 5, article e164 10.1038/cddis.2011.48 2-s2.0-79960024581
56. Welker M. W., Trojan J., Antiangiogenic treatment in hepatocellular carcinoma: the balance of efficacy and safety. Cancer Management and Research 2013 5 337 347
57. Liu L., Ho R. L. K., Chen G. G., Lai P. B. S., Sorafenib inhibits hypoxia-inducible factor-1alpha synthesis: implications for antiangiogenic activity in hepatocellular carcinoma. Clinical Cancer Research 2012 18 20 5662 5671 10.1158/1078-0432.CCR-12-0552 2-s2.0-84867531311
58. Wang W., Xu G., Jia W. D., Wang Z., Li J., Ma J., Ge Y., Xie S., Hu J., Expression and correlation of hypoxia-inducible factor-1 α vascular endothelial growth factor and microvessel density in experimental rat hepatocarcinogenesis. Journal of International Medical Research 2009 37 2 417 425 10.1177/147323000903700217 2-s2.0-66649084445
59. Lee K., Zhang H., Qian D. Z., Rey S., Liu J. O., Semenza G. L., Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization. Proceedings of the National Academy of Sciences of the United States of America 2009 106 42 17910 17915 10.1073/pnas.0909353106 2-s2.0-70449580319
60. Rey S., Semenza G. L., Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. Cardiovascular Research 2010 86 2 236 242 10.1093/cvr/cvq045 2-s2.0-77951698149
61. Kim J. W., Hypoxia-inducible factor 1, hepatocellular carcinoma and angiogenesis. The Korean journal of hepatology 2010 16 3 278 279 10.3350/kjhep.2010.16.3.278 2-s2.0-79959502574
62. Lu X., Kang Y., Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clinical Cancer Research 2010 16 24 5928 5935 10.1158/1078-0432.CCR-10-1360 2-s2.0-78650373860
63. Imai T., Horiuchi A., Wang C., Oka K., Ohira S., Nikaido T., Konishi I., Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells. The American Journal of Pathology 2003 163 4 1437 1447 10.1016/S0002-9440(10)63501-8 2-s2.0-0141760411 (Pubitemid 37175091)
64. Yang M.-H., Wu M.-Z., Chiou S.-H., Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nature Cell Biology 2008 10 3 295 305 10.1038/ncb1691 (Pubitemid 351331016)
65. Krishnamachary B., Zagzag D., Nagasawa H., Rainey K., Okuyama H., Baek J. H., Semenza G. L., Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Research 2006 66 5 2725 2731 10.1158/0008-5472.CAN-05-3719 2-s2.0-33645090169
66. Zhang L., Huang G., Li X., Zhang Y., Jiang Y., Shen J., Liu J., Wang Q., Zhu J., Feng X., Dong J., Qian C., Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1 α in hepatocellular carcinoma. BMC Cancer 2013 13, article 108 10.1186/1471-2407-13- 108 2-s2.0-84874729595
67. Sato H., Kida Y., Mai M., Endo Y., Sasaki T., Tanaka J., Seiki M., Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene 1992 7 1 77 83 2-s2.0-0026515761
68. Okazaki I., Inagaki Y., Novel strategies for hepatocellular carcinoma based on MMPs science. Anti-Cancer Agents in Medicinal Chemistry 2012 12 7 753 763 10.2174/187152012802650165 2-s2.0-84866369296
69. Ding J. Y., Kreipke C. W., Schafer P., Schafer S., Speirs S. L., Rafols J. A., Synapse loss regulated by matrix metalloproteinases in traumatic brain injury is associated with hypoxia inducible factor-1 α expression. Brain Research 2009 1268 125 134 10.1016/j.brainres.2009.02.060 2-s2.0-64149122741
70. Erdozain O. J., Pegrum S., Winrow V. R., Horrocks M., Stevens C. R., Hypoxia in abdominal aortic aneurysm supports a role for HIF-1 α and Ets-1 as drivers of matrix metalloproteinase upregulation in human aortic smooth muscle cells. Journal of Vascular Research 2011 48 2 163 170 10.1159/000318806 2-s2.0-77957748627
71. Fujiwara S., Nakagawa K., Harada H., Nagato S., Furukawa K., Teraoka M., Seno T., Oka K., Iwata S., Ohnishi T., Silencing hypoxia-inducible factor-1 α inhibits cell migration and invasion under hypoxic environment in malignant gliomas. International Journal of Oncology 2007 30 4 793 802 2-s2.0-34247847903
72. Xiang Z. L., Zeng Z. C., Fan J., Tang Z., Zeng H., Gao D., Gene expression profiling of fixed tissues identified hypoxia-inducible factor-1 α VEGF, and matrix metalloproteinase-2 as biomarkers of lymph node metastasis in hepatocellular carcinoma. Clinical Cancer Research 2011 17 16 5463 5472 10.1158/1078-0432.CCR-10-3096 2-s2.0-80051684246
73. Choi S. H., Shin H. W., Park J. Y., Yoo J. Y., Kim D. Y., Ro W. S., Yun C., Han K., Effects of the knockdown of hypoxia inducible factor-1alpha expression by adenovirus-mediated shRNA on angiogenesis and tumor growth in hepatocellular carcinoma cell lines. The Korean Journal of Hepatology 2010 16 3 280 287 10.3350/kjhep.2010.16.3.280 2-s2.0-79959525084
74. Charlton M., Leise M. D., Corrections: hypoxia-inducible factor 1 alpha-activated angiopoietin-like protein 4 contributes to tumor metastasis via vascular cell adhesion molecule-1/integrin β 1 signaling in human hepatocellular carcinoma. Hepatology 2011 54 6, article 2280 10.1002/hep.24669 2-s2.0-82455167749
75. Liu Y., Zhang J. B., Qin Y., Wang W., Wei L., Teng Y., Guo L., Zhang B., Lin Z., Liu J., Ren Z., Ye Q., Xie Y., PROX1 promotes hepatocellular carcinoma metastasis by way of up-regulating hypoxia-inducible factor 1 α expression and protein stability. Hepatology 2013 58 2 692 705 10.1002/hep.26398 2-s2.0-84880973278
76. Zhang Q., Bai X., Chen W., Ma T., Hu Q., Liang C., Xie S., Chen C., Hu L., Xu S., Liang T., Wnt/ β -catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1 α signaling. Carcinogenesis 2013 34 5 962 973 10.1093/carcin/bgt027 2-s2.0-84877157115
77. Yoshimura M., Itasaka S., Harada H., Hiraoka M., Microenvironment and radiation therapy. BioMed Research International 2013 2013 13 685308 10.1155/2013/685308 2-s2.0-84874607439
78. Schwartz D. L., Bankson J., Bidaut L., He Y., Williams R., Lemos R., Thitai A. K., Oh J., Volgin A., Soghomonyan S., Yeh H., Nishii R., Mukhopadhay U., Alauddin M., Mushkudiani I., Kuno N., Krishnan S., Bornman W., Lai S. Y., Powis G., Hazle J., Gelovani J., HIF-1-dependent stromal adaptation to ischemia mediates in vivo tumor radiation resistance. Molecular Cancer Research 2011 9 3 259 270 10.1158/1541-7786.MCR-10-0469 2-s2.0-79952857009
79. Meijer T. W., Kaanders J. H., Span P. N., Bussink J., Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy. Clinical Cancer Research 2012 18 20 5585 5594 10.1158/1078-0432.CCR-12-0858 2-s2.0-84867514301
80. Yang W., Sun T., Cao J., Fan S., Hypoxia-inducible factor-1 α downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and enhances radiosensitivity in chemical hypoxic human hepatoma SMMC-7721 cells. Cancer Biotherapy and Radiopharmaceuticals 2011 26 5 565 571 10.1089/cbr.2011.0955 2-s2.0-80054685625
81. Xiang Z., Zeng Z., Fan J., Tang Z., He J., Zeng H., Chang J. Y., The expression of HIF-1 α in primary hepatocellular carcinoma and its correlation with radiotherapy response and clinical outcome. Molecular Biology Reports 2012 39 2 2021 2029 10.1007/s11033-011-0949-1 2-s2.0-84860326868
82. Comerford K. M., Wallace T. J., Karhausen J., Louis N. A., Montalto M. C., Colgan S. P., Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Research 2002 62 12 3387 3394 2-s2.0-0037096732 (Pubitemid 34651384)
83. Cao Y., Eble J. M., Moon E., Tumor cells upregulate normoxic HIF-1 α in response to doxorubicin. Cancer Research 2013 73 20 6230 6242 10.1158/0008-5472.CAN-12-1345
84. Zhu H., Luo S., Wang J., Li X., Wang H., Pu W., Zhang H., Zhuang Z., Effect of environmental factors on chemoresistance of HepG2 cells by regulating hypoxia-inducible factor-1 α Chinese Medical Journal 2012 125 6 1095 1103 10.3760/cma.j.issn.0366-6999.2012.06.024 2-s2.0-84862266744
85. Tung J.-N., Cheng Y.-W., Hsu C.-H., Liu T., Hsieh P., Ting L., Ko H., Chang Y., Chiou J., Wu A. T. H., Normoxically overexpressed hypoxia inducible factor 1-alpha is involved in arsenic trioxide resistance acquisition in hepatocellular carcinoma. Annals of Surgical Oncology 2011 18 5 1492 1500 10.1245/s10434-010-1444-y 2-s2.0-79955866746
86. Li S., Yao D., Wang L., Expression characteristics of hypoxia-inducible factor-1 α and its clinical values in diagnosis and prognosis of hepatocellular carcinoma. Hepatitis Monthly 2011 11 10 821 828
87. Simon F., Bockhorn M., Praha C., Baba H. A., Broelsch C. E., Frilling A., Weber F., Deregulation of HIF1-alpha and hypoxia-regulated pathways in hepatocellular carcinoma and corresponding non-malignant liver tissue-influence of a modulated host stroma on the prognosis of HCC. Langenbeck's Archives of Surgery 2010 395 4 395 405 10.1007/s00423-009-0590-9 2-s2.0-77954667202
88. Dai C., Gao Q., Qiu S., Ju M., Cai M., Xu Y., Zhou J., Zhang B., Fan J., Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery. BMC Cancer 2009 9, article 418 10.1186/1471-2407-9-418 2-s2.0-73249152662
89. Zheng S., Chen X., Yin X., Zhang B., Prognostic significance of HIF-1a expression in hepatocellular carcinoma: a meta-analysis. PLoS ONE 2013 8 6 e65753 10.1371/journal.pone.0065753 2-s2.0-84879057163
90. Cao S., Yang S., Wu C., Protein expression of hypoxia-inducible factor-1 alpha and hepatocellular carcinoma: a systematic review with meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2014 S2210-7401 14
91. Sadri N., Zhang P. J., Hypoxia-inducible factors: mediators of cancer progression; prognostic and therapeutic targets in soft tissue sarcomas. Cancers 2013 5 2 320 333 10.3390/cancers5020320 2-s2.0-84876453861
92. Semenza G. L., Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends in Pharmacological Sciences 2012 33 4 207 214 10.1016/j.tips.2012.01.005 2-s2.0-84859445000
93. Shan H. L., Dong H. S., Chun Y., Myung K. L., Kim M., Park J., A novel mode of action of YC-1 in HIF inhibition: stimulation of FIH-dependent p300 dissociation from HIF-1 α Molecular Cancer Therapeutics 2008 7 12 3729 3738 10.1158/1535-7163.MCT-08-0074 2-s2.0-57749106966
94. Shin D. H., Kim J., Jung Y., Kim K., Jeong J. M., Chun Y., Park J., Preclinical evaluation of YC-1, a HIF inhibitor, for the prevention of tumor spreading. Cancer Letters 2007 255 1 107 116 10.1016/j.canlet.2007.03.026 2-s2.0-34547660100 (Pubitemid 47212610)
95. Liang Y., Zheng T., Song R., Wang J., Yin D., Wang L., Liu H., Tian L., Fang X., Meng X., Jiang H., Liu J., Liu L., Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1 α inhibition in hepatocellular carcinoma. Hepatology 2013 57 5 1847 1857 10.1002/hep.26224 2-s2.0-84876743991
96. Yamasaki M., Nagatomo T., Matsuyama T., Ikeho Y., Kato E., Nishiyama K., Sakakibara Y., Suiko M., Nishiyama K., Conjugated linoleic acids inhibit hypoxia inducible factor-1 α stabilization under hypoxic condition in human hepatocellular carcinoma cells. Journal of Oleo Science 2012 61 9 491 496 10.5650/jos.61.491 2-s2.0-84869046984
97. Tanaka H., Li Z., Ikuta K., Addo L., Akutsu H., Nakamura M., Sasaki K., Ohtake T., Fujiya M., Torimoto Y., Glass J., Kohgo Y., Iron facilitator LS081 reduces hypoxia-inducible factor-1 α protein and functions as anticancer agent in hepatocellular carcinoma. Cancer Science 2012 103 4 767 774 10.1111/j.1349-7006.2011.02192.x 2-s2.0-84862800293
98. Liang B., Zheng C., Feng G., Wu H., Wang Y., Zhao H., Qian J., Liang H., Correlation of hypoxia-inducible factor 1 α with angiogenesis in liver tumors after transcatheter arterial embolization in an animal model. CardioVascular and Interventional Radiology 2010 33 4 806 812 10.1007/s00270-009-9762-9 2-s2.0-77956184282
99. Liang B., Zheng C., Feng G., Wang Y., Zhao H., Liang H., Xiao E., Expression of hypoxia-inducible factor-1 α in liver tumors after transcatheter arterial embolization in an animal model. Journal of Huazhong University of Science and Technology-Medical Science 2009 29 6 776 781 10.1007/s11596-009-0621-3 2-s2.0-77149128349
100. Liang B., Zheng C., Feng G., Wu H., Wang Y., Zhao H., Li X., Qian J., Liang H., Experimental evaluation of inhibitory effect of 10-hydroxycamptothecin on hypoxia-inducible factor-1 α expression and angiogenesis in liver tumors after transcatheter arterial embolization. Journal of Vascular and Interventional Radiology 2010 21 10 1565 1572 10.1016/j.jvir.2010.05.028 2-s2.0-77957815559
101. Mollaie H. R., Monavari S. H., Arabzadeh S. A., RNAi and miRNA in viral infections and cancers. Asian Pacific Journal of Cancer Prevention 2013 14 12 7045 7056
102. Lee J. M., Yoon T. J., Cho Y. S., Recent developments in nanoparticle-based siRNA delivery for cancer therapy. BioMed Research International 2013 2013 782041 10.1155/2013/782041 2-s2.0-84880144292
103. Callegari E., Elamin B. K., Sabbioni S., Role of microRNAs in hepatocellular carcinoma: a clinical perspective. OncoTargets and Therapy 2013 6 1167 1178 10.2147/OTT.S36161
104. Uchino K., Ochiya T., Takeshita F., RNAi therapeutics and applications of microRNAs in cancer treatment. Japanese Journal of Clinical Oncology 2013 43 6 596 607 10.1093/jjco/hyt052 2-s2.0-84878630603
105. Wu Y., Xu L., Ni J., Sun H., Chen Y., Effects of hypoxia-inducible factor-1 α silencing on the proliferation of cbrh-7919 hepatoma cells. World Journal of Gastroenterology 2013 19 11 1749 1759 10.3748/wjg.v19.i11.1749 2-s2.0-84875395847
106. Chen C., Wang J., Liu R., Qian S., RNA interference of hypoxia-inducible factor-1 alpha improves the effects of transcatheter arterial embolization in rat liver tumors. Tumour Biology 2012 33 4 1095 1103 10.1007/s13277-012-0349-8 2-s2.0-84867626275
107. WeiXing C., Tiantian H., Qun N., Chaohui Y., Ping X., Inhibitory effect of Hypoxia inducible factor-1 antisense oligonucleotide on growth of human hepatocellular carcinoma cells. Medical Oncology 2008 25 1 88 92 10.1007/s12032-007-0050-8 2-s2.0-42949088151
108. Liu F., Wang P., Jiang X., Tan G., Qiao H., Jiang H., Krissansen G. W., Sun X., Antisense hypoxia-inducible factor 1 α gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma. Cancer Science 2008 99 10 2055 2061 10.1111/j.1349-7006.2008.00905.x 2-s2.0-54949123005